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Abstract
Background: The neuropsychological arm of the International Subarachnoid Aneurysm Trial (N-
ISAT) evaluated the cognitive outcome of 573 patients at 12 months following subarachnoid
haemorrhage (SAH). The assessment included 29 psychometric measures, yielding a substantial and
complex body of data. We have explored alternative and optimal methodologies for analysing and
summarising these data to enable the estimation of a cognitive complication rate (CCR). Any
differences in cognitive outcome between the two arms of the trial are not however reported here.
Methods: All individual test scores were transformed into z-scores and a 5th percentile cut-off for
impairment was established. A principal components analysis (PCA) was applied to these data to
mathematically transform correlated test scores into a smaller number of uncorrelated principal
components, or cognitive 'domains'. These domains formed the basis for grouping and weighting
individual patients' impaired scores on individual measures. In order to increase the sample size, a
series of methods for handling missing data were applied.
Results: We estimated a 34.1% CCR in all those patients seen face-to-face, rising to 37.4% CCR
with the inclusion of patients who were unable to attend assessment for reason related to the index
SAH. This group demonstrated significantly more self and carer/relative rated disability on a Health
Related Quality of Life questionnaire, than patients classified as having no functionally significant
cognitive deficits.
Conclusion:  Evaluating neuropsychological outcome in a large RCT involves unique
methodological and organizational challenges. We have demonstrated how these problems may be
addressed by re-classifying interval data from 29 measures into a dichotomous CCR. We have
presented a 'sliding scale' of undifferentiated individual cognitive impairments, and then on the basis
of PCA-derived cognitive 'domains', included consideration of the distribution of impairments in
these terms. In order to maximize sample size we have suggested ways for patients who did not
complete the entire protocol to be included in the overall CCR.
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Background
The International Subarachnoid Aneurysm Trial (ISAT) is
the largest ever randomized trial in the treatment of sub-
arachnoid haemorrhage (SAH). Clinical outcomes have
been reported at 2 months and 1 year, following neuro-
surgical clipping or endovascular coiling as a treatment for
ruptured intracranial aneurysm [1,2]. The primary out-
come was the proportion of patients with Modified
Rankin Scale (mRS) grades 3–6 (i.e., dependency or
death). ISAT presented an opportunity to explore 'second-
ary' neuropsychological outcomes following these inter-
ventions, which was exploited by assessing patients
randomized into ISAT across 8 UK centres, who were sur-
viving 12 months after treatment [3]. This sample repre-
sented a UK sub-group of the main ISAT trial and will be
referred to as N-ISAT.
N-ISAT represents a clinical dataset that is unique in its
size and complexity. Trained examiners administered a
neuropsychological battery to 573 patients; other clinical
interview and quality of life questionnaire data were also
obtained. Other than the results from one questionnaire,
these data are not reported here. The test battery needed to
sample a range of intelligent behaviours with sufficient
sensitivity to detect the quality of impairments that might
be associated with a heterogeneous distribution of SAH
lesions; this involved 29 measures drawn from 21 tests. A
detailed battery was preferred to enable the exploration of
more selective brain-behaviour relationships, and impor-
tantly, to minimize the potential for type 2 audit errors.
For example, a battery of insufficient range and sensitivity
might fail to identify potentially disabling deficits in exec-
utive skills. However, a comprehensive range of neuropsy-
chological tests scores is far from ideal from the point of
view of communicating outcomes parsimoniously to neu-
ropsychologically naïve trial, medical or patient audi-
ences.
Cognitive outcomes are routinely reported by employing
parametric inferential statistics. For example a multivari-
ate procedure comparing two arms of a randomised trial
across a range of tests to investigate where preferential
cognitive outcomes lie. However even if consistent group
differences are identified across a test battery in favour of
one or other trial arm, these would be small, (in terms of
raw scores) revealing little about their clinical significance
or meaning, and nothing about the number of clinically
impaired individual outcomes. A more significant diffi-
culty with this approach is that cognitive outcomes appear
to be non-orthogonal in relation to outcomes as meas-
ured in terms of handicap scales [4]. Thus, if secondary
cognitive outcomes are to be mapped meaningfully onto
primary trial outcomes that have already been 'dichot-
omized' (i.e., in terms of the proportion of dependent or
dead, as opposed to alive independent patients), then
cognitive outcomes must also be classified into 'handi-
capped' versus 'non-handicapped' individuals. Only then
would it be possible to determine any differences between
the two arms of a trial in terms of the degree of any 'addi-
tional' cognitive disability.
The task of identifying individuals with a cognitive 'com-
plication' (i.e., a classification of 'significant cognitive
impairment') involves two key challenges. The first is
determining where to place an appropriate 'cut-off' on
individual test scores, (i.e., below which a performance
can be said to be 'significantly' impaired). A score may for
example be judged relative to that individual's estimated
pre-morbid state, a normal control population, or an
equivalent clinical population, with each perspective hav-
ing both advantages and disadvantages. The second chal-
lenge is concerned with determining how multiple test
scores are to be summarized or distilled down into a
smaller number of cognitive constructs or 'domains'. Thus
for example a particular constellation of impaired tests
scores might be said to represent an impairment in lan-
guage, spatial memory or executive skills. An individual
might be impaired in one or more of these domains (with
more or less consistency across tests), and a determination
would need to be made about whether that crossed the
threshold of functional or clinical significance.
The selection of an optimum number of cognitive
domains to encapsulate a data set, and the allocation of
individual tests to these domains, are tasks that can be
achieved simultaneously and empirically by a principal
components analysis (PCA). A PCA aims to mathemati-
cally transform (possibly) correlated test scores into a
smaller number of uncorrelated principal components or
underlying 'factors', while retaining most of the original
variability in the data set. Examination of the distribution
of tests, and their loadings, represented in the underlying
structure (i.e., the 'factors') of the data set, should enable
the mapping of factors onto recognizable cognitive
'domains'. A drawback of this approach is that the pat-
terns of shared variance, though empirically-derived,
reflect the neuropsychological characteristics of the index
clinical population rather than a normal control group
[5]. The cognitive domains derived from a PCA would
therefore be essentially un-reproducible. An alternative
approach is to postulate a priori, or on the basis of explicit
criteria, a number of cognitive 'domains' purported to be
sampled by selected tests in the battery; a 'composite'
domain score can then be obtained by summarizing the
relevant individual test scores. This approach is reproduc-
ible and allows for the referencing of individuals' test
scores against normal (or individual pre-morbid) control
data, however the selection of domains and the tests that
comprise them, may be criticized as being relatively arbi-
trary.Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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This paper explores and presents explicitly, these and
other methods that were applied to the task of estimating
a cognitive complication rate (CCR) for the N-ISAT data
set. The reduction of sensitive interval data yielded by a
battery of neuropsychometric tests down into binary out-
comes is a retrograde step from the point of view of the
richness of the data and the dangers of dichotomisation.
However this is what routinely occurs in clinical neu-
ropsychological practise, where the results of various
investigations and presenting factors are weighed and an
'impaired' versus a 'not impaired' judgement is made.
With no available or agreed method, benchmark, test or
scale for determining a 'cognitively impaired' classifica-
tion, the 'gold standard' is, by default, an expert neuropsy-
chological opinion. With this measure unavailable in a
large multi-centre RCT, it follows that, in the first instance,
there is no external validation criterion available check the
reliability or validity of classifications based upon a
numerical algorithm. The task here is therefore to match
and mirror the process of expert clinical neuropsycholog-
ical classification in our analysis of the N-ISAT data set as
systematically and transparently as possible. By illustrat-
ing the consequences (i.e., for an estimated CCR) of vari-
ous assumptions and techniques of analysis, we would
hope to accommodate a range of clinical opinion and
expose our methods to constructive criticism but at the
same time, work toward developing a reproducible heu-
ristic that may be of assistance in similar studies.
Methods
Patients and design
Multicentre ethical approval was given by Oxford REC A
(reference number: 98/5/73). All patients gave informed
consent. In May 2002, recruitment to ISAT was closed. At
this time point 836 patients had been enrolled in the 8 UK
centers participating in N-ISAT (between June 1997 and
November 2001) of whom 771 were alive at 12 months.
This 'available' sample of 771 was invited to attend neu-
ropsychological follow-up. Of the 713 who could be con-
tacted, 573 were eventually seen for face-to-face
assessment.
Cognitive assessments
The N-ISAT assessment battery was designed to sample
cognitive function comprehensively; it has been described
and referenced in detail elsewhere [3]. There were 29
measures drawn from 21 psychometric tests. For the pur-
poses of accommodating a range of patient disability and
disposition, the test battery was organized a priori into
'screening', 'core' and 'full' protocols of increasing length
and sensitivity [3]. For the purposes of the analysis here,
the 'core' protocol included all the 'pencil and paper' tests
and comprised 22 measures drawn from 15 tests (see
Table 1). The 'full' protocol comprised the 'core' battery
plus an additional 7 measures from 6 computerised tests
(see Table 2). Neuropsychological tests frequently yield
more than one measure. Some (i.e., the CANTAB battery
of tests) yield very many, while others (i.e., SCOLP) yield
essentially only one. Here, the measures employed were
either those most widely validated and employed in clin-
ical practise, or those that most selectively target the cog-
nitive region of interest.
All tests were always administered in the same sequence,
beginning with pre-assessment screening, followed by the
'core' protocol through to complete the 'full' protocol.
This strategy aimed to maximize the chances that a con-
sistent minimum data set (i.e., 'core') would be obtained.
Analyses
The N-ISAT raw data set was transformed into standard-
ized z-scores (with a mean of 0 and a standard deviation
of 1) relative to age-matched normal populations,
employing standard reference manuals and materials [3].
In line with widely accepted clinical practice Individuals'
test scores that fell at or below the 5th percentile (equiva-
lent to a z-score ≤ -1.645) were then identified and classi-
fied as impaired scores or 'deficits'.
Raw test scores from all patients who completed the 'core'
and then 'full' protocols were included in a PCA in order
to yield an empirical guide to reducing the number of
dependent outcomes. A priori evidence suggests that while
different aspects of cognitive function may be relatively
independent, they are not fully orthogonal and instead
co-vary. Therefore a non-orthogonal oblique rotation
(promax) was undertaken on the 2 different samples of
patients who completed the 'core' and the 'full' test proto-
cols. These analyses yielded 4 and 6 factor solutions
respectively. The factors were all related, to a greater or
lesser extent to each cognitive test score, and in addition,
to each other. Individual's z-scores on each factor were
then examined in order to identify patients whose scores
fell at or below the 5th percentile (equivalent to a z-score
≤ -1.645). These individual factor scores were not used to
estimate a CCR.
Following the classification of patients on the basis of
their neuropsychometric test scores into 'impaired' and
'not-impaired' groups, we examined differences in group
summary scores taken from self and relative/carer rated
UK version of the Sickness Impact Profile Quality of Life
questionnaire [6] using an independent samples t-test.
Missing data
A preliminary examination of missing data has already
been published [3]. In the analysis here every attempt was
made to maximize the sample sizes in the calculation of a
CCR; missing data were therefore re-examined. We found
a substantial number of patients who failed to completeTrials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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the 'core' or 'full' batteries, but for whom many measures
were available. For example, of the 567 patients who
passed the initial screening assessment and were seen
face-to-face, all but 28 completed more than 20 measures.
Here there was sufficient available test data to enable a
determination of whether there was cognitive impair-
ment, though failure to complete (or acquire) one or two
measures had potentially excluded patients from a CCR
based on full or core protocols. We therefore explored
ways to include these cases in the overall CCR.
In addition we included missing data into the CCR analy-
ses, where failure to complete a test had been contempo-
raneously classified by examiners as "SAH related" (as
opposed to "SAH-unrelated") [3]. If coded "SAH-related",
then the cause of the missing data was attributed to seque-
lae associated with the index subarachnoid haemorrhage
(i.e., aphasia, sensory deficit, under 24 hour care). Failure
to complete a test in this context was therefore conceptu-
alized as a clinically meaningful endpoint, equivalent to
an impoverished score on that test.
As the N-ISAT test battery had been administered in the
same order it was possible to infer additional reasons for
some missing data. For example the CANTAB computer-
ized tests were routinely administered after patients had
completed the 'core' protocol of 'pencil and paper' tests,
and following a scheduled break (i.e., for lunch) in the
assessment day. Therefore, if patients had already encoun-
tered difficulties coping with the 'core' battery of tests
there might be a tendency for the remainder of the assess-
ment to be abandoned (by examiner, patient or both) at
this point in the day. If such missing data had been coded
as 'SAH-related", the examiner would have had grounds
for believing that patients' presentation up until that
point in the assessment suggested they would not, or
could not cope with further assessment. The structure of
the assessment therefore impacted on the distribution of
missing data.
A 'sliding scale' CCR
Having transformed the raw scores on each of the 29
measures into z-scores, we then identified all those scores
that fell at or below the 5th percentile. All these measures
were assumed, potentially, capable of sampling a rela-
tively selective cognitive deficit (in line with the rationale
underlying their inclusion in the test battery), and were
therefore included in the analysis on an equivalent basis.
However, with four particular pairs of test measures (i.e.,
AMIPB immediate and delayed recall, the Rey figure
Table 1: Pattern matrix of correlations between the four principal components and individual neuropsychological tests. (correlations 
between -0.10 to 0.10 are not shown and correlations > 0.40 and <-0.40 are in bold). The factors explaining the greatest degree of 
variance was 1, followed by 2, 4 and 3.
Neuropsychological Tests Factors and cognitive domain labels
1 (VM) 2 (GVS) 3 (PS) 4 (NVS-M)
AMIPB story immediate recall (IR) 0.56 0.57 -0.29
AMIPB story delayed recall (DR) 0.64 0.49 -0.29
CVLT word list learning trials 1–5 0.81 0.22
CVLT Short delay free recall 0.88 -0.17 0.20
CVLT Long delay free recall 0.90 -0.17 0.12
WAIS-R digit span -0.27 0.63 0.16 0.22
WAIS-R vocabulary 0.85
WAIS-R block design -0.16 0.27 0.21 0.65
WAIS-R arithmetic -0.21 0.69 0.13 0.22
WAIS-R similarities 0.60 0.22
Rey figure copy -0.10 0.16 0.71
Rey figure immediate recall (IR) 0.23 -0.12 0.85
Rey figure delayed recall (DR) 0.26 -0.12 0.85
Phonemic verbal fluency 0.40 0.56 -0.14
Semantic verbal fluency 0.23 0.33 0.44 -0.18
RMT words 0.49 0.13 0.21
RMT faces 0.34 -0.22 0.13 0.25
Boston naming (no. correct) 0.15 0.38 0.25 0.10
SCOLP 0.17 0.28 0.70 -0.27
SDMT written 0.77 0.22
SDMT oral 0.11 0.75 0.22
VM = verbal memory; GVS = general verbal skills; PS = processing speed; SWM = spatial working memory; NVS-M = non-verbal skills/memory; ES 
= executive skills. AMIPB = Adult Memory and Information Processing Battery; CVLT = California Verbal Learning Test; WAIS-R = Wechsler Adult 
Intelligence Scale Revised; RMT = Warrington Recognition Memory Test.Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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immediate and delayed recall, the CVLT short and long
delay recall and the SDMT written and oral subtests) we
included the mean of the two measures rather than each
measure independently in the sliding scale totals. This
refinement was necessary as there was a high probability
that a deficit on one of these measures would be associ-
ated with a deficit on the other in the pair; indeed the
subtest scores of each pair were all found to correlate sig-
nificantly ≥ 0.9 (p < .001).
We then calculated the percentage of individuals with
scores at ≥ 5 th percentile on an escalating number (i.e.,
0–10) of measures. This sliding scale of cognitive impair-
ments was calculated for the 'core' and 'full' samples, and
then for all patients who had completed at least 10 meas-
ures. To further simplify these data, individuals' deficits
on the sliding scale were classified into 4 categories.
Where there was ≤ 1 impaired test score, patients were
classified as having "no deficit"; 2 or 3 impairments were
classified as a "mild" deficit, and 4, 5 or 6 impairments as
a "moderate" deficit. Patients with ≥ 7 impaired test scores
were classified as having a "severe" deficit.
Classifications at the two extremes of this distribution are
not in our view controversial. However across the mild-
moderate levels of impairment we would anticipate diffi-
culties identifying a cut-off to differentiate those patients
with a clinically or functionally significant level of impair-
ment from those without. Clinical experience suggests
that in the critical range of approximately 4–6 test deficits,
determining where and with what degree of consistency defi-
cits lie, can have an crucial bearing on whether a patient
was likely to be functionally impaired. For example, 3 or
4 deficits selectively targeting delayed recall measures of
Table 2: Pattern matrix of correlations between the six principal components and individual neuropsychological tests. (correlations 
between -0.10 to 0.10 are not shown and correlations > 0.40 and <-0.40 are in bold). The factors explaining the greatest degree of 
variance was 1, followed by 3, 2, 5, 4 and 6.
Neuropsychological Tests Factors and cognitive domain labels
1 (VM) 2 (GVS) 3 (PS) 4 (NVS-M) 5 (SWM) 6 (ES)
AMIPB story immediate recall (IR) 0.55 0.61 -0.26
AMIPB story delayed recall (DR) 0.63 0.53 -0.26
CVLT word list learning trials 1–5 0.82 0.21
CVLT Short delay free recall 0.87 0.17
CVLT Long delay free recall 0.89 -0.10
WAIS-R digit span -0.19 0.58 0.27 0.18 0.31
WAIS-R vocabulary 0.79 0.18 -0.13 -0.10
WAIS-R block design -0.16 0.19 0.14 0.54 0.22 -0.15
WAIS-R arithmetic -0.10 0.67 0.12 0.21 0.17
WAIS-R similarities 0.54 0.31 -0.19
Rey figure copy -0.17 0.19 0.68
Rey figure immediate recall (IR) 0.18 -0.13 0.91
Rey figure delayed recall (DR) 0.20 -0.13 0.92
Phonemic verbal fluency 0.36 0.62 -0.13
Semantic verbal fluency 0.18 0.34 0.49 -0.19 -0.11
RMT words 0.43 0.16 0.24
RMT faces 0.27 -0.20 0.23 0.34 -0.26
Boston naming (no. correct) 0.35 0.27 0.18 -0.20 -0.28
SCOLP 0.12 0.27 0.77 -0.28
SDMT written 0.78 0.19
SDMT oral 0.14 -0.10 0.75 0.19
CANTAB IED adjusted errors score 0.15 -0.19 0.87
CANTAB Spatial span -0.11 0.13 0.12 0.53
CANTAB SWM strategy score -0.10 0.23 -0.80 0.13
CANTAB SWM between errors score -0.13 -0.79 0.14
CANTAB SOC minimum move solutions 0.13 -0.20 0.16 0.55
CANTAB PAL total trials -0.39 0.22 -0.13 -0.15 -0.12 0.23
CANTAB RVIP 'A' prime 0.14 0.58 0.24 0.23
VM = verbal memory; GVS = general verbal skills; PS = processing speed; SWM = spatial working memory; NVS-M = non verbal skills/memory; ES 
= executive skills. AMIPB = Adult Memory and Information Processing Battery; CVLT = California Verbal Learning Test; WAIS-R = Wechsler Adult 
Intelligence Scale Revised; RMT = Warrington Recognition Memory Test; CANTAB = Cambridge Neuropsychological Test Automated Battery; IED 
= intradimensional/extradimensional set-shifting task; SWM = Spatial Working Memory task; SOC = Stockings of Cambridge task; PAL = Paired 
Associate Learning task; RVIP = Rapid Visual Informational Processing task.Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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memory might be indicative of a functionally significant
amnesia, but 3 or 4 deficits distributed more randomly
across the test battery might reflect nothing more than a
combination of low pre-morbid ability and/or disposi-
tional factors. These considerations were therefore incor-
porated into a 'cognitive domain specific CCR'.
A cognitive domain specific CCR
In order to make allowance for the internal consistency of
deficits across the test battery, we grouped measures into
cognitive 'domains' based upon the six factors that
emerged from the PCA analysis of the 'full' sample; refer-
ence was also made to the four factor solution that
emerged from the 'core' sample. We first identified those
key measures in each of the 6 PCA-derived cognitive
'domains' with loadings greater than 0.4 for that factor as
follows:
1. Verbal Memory (VM): AMIPB and CVLT subtests, RMT
'words'.
2. General Verbal skills (GVS): AMIPB and all WAIS-R sub-
tests except Block Design (n.b., phonemic verbal fluency
in 4 factor solution).
3. Processing Speed (PS): SCOLP, SDMT, RVIP and verbal
fluencies.
4. Non-verbal Skills/memory (NVS-M): Rey copy &
delays, Block Design.
5. Spatial Working Memory (SWM): all CANTAB subtests
except IED and PAL.
6. Executive skills (ES): CANTAB IED.
Clinical experience suggested that a criterion of impaired
z-scores (i.e., ≤ 5th percentile) on 2 or more of these key
measures (for each of the 6 PCA-derived domains), would
adequately define a 'domain specific' deficit. Nevertheless
two particular measures presented difficulties in this
respect as they were represented across PCA-derived
domains (see above). The AMIPB subtests loaded on both
the VM factor and GVS factors (see Table 2), and verbal
fluencies (though not reaching criterion except on the
four factor solution) showed a trend (that was consistent
with clinical experience), of loading on GVS and PS.
Therefore, to avoid double counting domain specific def-
icits, we calculated a mean score for the 2 AMIPB (imme-
diate and delayed recall) subtests and included this
variable in both the GDS and VM domains. We also cross-
checked all analyses with verbal fluencies placed in both
the PS and GVS domains.
In order to identify a cognitively impaired individual the
algorithm of 2 or more deficits in 2 or more factor-derived
cognitive domains would be equivalent to identifying
patients with deficits on 4 tests, but unlike the sliding
scale, would exclude patients with deficits more randomly
distributed across the battery, and rather target patients
with greater internal consistency in the distribution of
their deficits.
Results
Sampling
Between June 1997 and November 2001 836 patients
were randomised into ISAT across the 8 N-ISAT UK cen-
tres. However, 65 died before 12-month follow-up, 198
were lost to N-ISAT follow-up and a further 197 of those
573 patients who presented for face-to-face assessment
failed to complete the full neuropsychological test battery.
A complete neuropsychological data set was therefore
only available on 376 patients, though mRS grades were
available for 828. Despite a rigorous and systematic
attempt in N-ISAT to minimize and then characterize loss
to follow-up [3], the non-random distribution of death
and major disability was a primary trial outcome, and out-
side the investigators' control. The distribution of full neu-
ropsychological data sets (or conversely, missing data)
across the two arms of N-ISAT was therefore non-random,
with only surviving patients 'available' for assessment,
and survivors with worse outcomes less likely to attend for
follow-up or complete the full test battery.
Of the 771 surviving patients theoretically available for
12-month neuropsychological follow-up, 29 (14.6%) did
not attend for reasons related to the original SAH (i.e., in
24 hour hospital care), 96 (48.5%) for unknown reasons
(i.e., couldn't be contacted), and 73 for reasons unrelated
to SAH (36.8%).
Of the 573 patients who presented for assessment, 6 failed
the pre-assessment screening protocol and 7 failed to
complete > 14 test measures (for a variety of reasons). Of
the remaining 560 presenting patients, 449 (80%) com-
pleted the 'core' test protocol, while 376 patients (67%)
completed the 'full' test protocol. However, fully 538
patients completed at least 20 measures. Though 25.6% of
the 771 patients who were theoretically available to N-
ISAT were never seen face-to-face for assessment, this was
primarily for reasons outside the control of N-ISAT inves-
tigators.
Missing data
We examined the distribution of missing data coded as
'SAH-related'. And found particular difficulties with CAN-
TAB test data. We examined all patients in the 'core' sample
who had SAH-related missing data on CANTAB tests.
From a total of 459 patients, 58 had failed to complete 1Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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or more CANTAB tests but fully 40 had failed to complete
over half this battery of 7 tests (i.e., 4 or more tests). Fur-
ther analysis indicated that the majority of these 40
patients were cognitively impaired, as judged on the basis
of their 'core' protocols, and would therefore be included
in the CCR on this basis without reference to their missing
CANTAB data. Of 31 patients who had SAH-related miss-
ing data on 5 or more CANTAB tests, 63% were for exam-
ple impaired according to the 'two domain' criterion
presented in Table 3.
By re-coding SAH-related missing data as 'impaired'
scores, the 'core' sample was increased from 449 to 509
(i.e., from 80% to 89% of available, presenting patients),
and the 'full' sample from 376 to 459 (i.e., from 66% to
82% of available presenting patients). Throughout our
findings detailed below, we provide estimated CCRs both
with and without the inclusion of these missing data.
Those patients who were unable to attend for assessment
for reasons related to the index SAH (n = 29) and those
who failed the screening assessment (n = 6) or failed to
complete > 14 test measures (n = 7), comprised an addi-
tional group of 42 patients who might to be included in a
CCR.
N-ISAT neuropsychological profile
Figure 1 presents the mean z-scores of the 376 patients
who completed all of the 29 neuropsychological measures
that comprise the 'full' protocol, and the mean z-scores on
all tests for all patients (regardless of how much of the bat-
tery each individual completed).
These profiles illustrate patients' scores relative to a nor-
mal control population. The mean test scores taken from
the 'full' sample of 376 patients suggested that general ver-
bal skills and estimated pre-morbid verbal IQ (NART)
clustered around the mean. On tests of verbal memory/
new learning ability (i.e., AMIPB and CVLT), patients'
scores, with some consistency, were shifted down by
approximately 0.4 – 0.8 of a standard deviation below the
mean. Similarly, on tests of executive skill (i.e., verbal flu-
ency, IED, SWM and SOC) scores were shifted down by
approximately 0.4 – 0.6 of a standard deviation. On tests
of psychomotor/processing speed and spatial skills, there
was less consistency in the apparent sensitivity of meas-
ures, with scores on the RVIP and Rey Copy shifted down
by approximately 0.8 of a standard deviation, whereas on
the SDMT and Block Design subtest (taken from WAIS-R),
scores were clustered around the mean.
Figure 1 illustrates that the mean scores of all measures
(i.e., regardless of the different sample sizes for each meas-
ure), are shifted down relative to the means from the con-
strained, smaller 'full' sample, suggesting that the 'core'
sample may have for exampled tended to exclude patients
with a more severe range of deficits.
Principal components analyses on 'full' and 'core' samples
The raw scores of 376 patients on the 28 measures that
comprise the 'full' protocol (excluding NART) were
entered into a principal components analysis (PCA) pro-
ducing a six-factor solution, which converged after 11 iter-
ations. The resulting pattern matrix (Table 2) shows the
factor loadings for each variable on the 6 factors, after
rotation. These factors may be considered empirically
derived cognitive 'domains', specifically relevant to this
clinical N-ISAT sample [5]. The pattern of correlations
between the 28 measures suggested a labelling of the fac-
tors as follows:
Factor 1: cognitive domain – "Verbal Memory"
The highest loadings on this factor include measures
taken from the robust neuropsychological paradigms of
Table 3: A CCR for the 'full' and 'core' samples. A CCR for the 'full' (i.e., 6 factor solution) and 'core' (i.e., 4 factor solution) samples; 
where 2+ deficits or 3+ deficits (i.e., test scores < 5th percentile) define a domain-specific deficit.
6 domains 4 domains
No. of domains with 
deficits
No missing data 
(n = 376)
Including missing data 
(n = 459)
No missing data 
(n = 449)
Including missing data 
(n = 509)
2+ measures 2+ measures
0 41.2 36.2 52.3 49.1
1 or more 58.8 63.8 47.7 50.9
2 or more 31.9 38.3 24.3 27.7
3 or more 13.3 22.9 10.2 13.8
3+ measures 3+ measures
0 54.3 47.5 67.5 63.1
1 or more 45.7 52.5 32.5 36.9
2 or more 17.3 25.7 13.1 16.1
3 or more 7.4 12.9 3.3 5.7Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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story recall, word list learning and word recognition that
evaluate verbal memory/new learning ability.
Factor 2: cognitive domain – "general verbal skill"
The highest loadings on this factor include key subtests
that comprise the Verbal Scale of the WAIS-R (i.e., Vocab-
ulary, Similarities, Arithmetic, Digit Span) together with
tests of verbal fluency (both phonemic and semantic).
High loadings were also present on the immediate and
delayed recall measures of the story recall. However, this
finding was not unexpected as, though the story recall task
is designed to assess verbal memory, general verbal skills
underpin the ability to grasp the essential narrative struc-
ture of the task, which in turn facilitates recall perform-
ance.
Factor 3: cognitive domain – "processing speed"
Though the measures with the highest loadings on this
factor represent a relatively heterogeneous constellation
of tests (i.e., verbal fluency, SDMT, SCOLP and RVIP),
they share a clearly defined commonality in so far as they
comprise every test in the protocol that is performed under
time pressure.
Factor 4: cognitive domain – "non-verbal skill and memory"
The highest loadings on this factor comprise measures of
the copy and recall of the Rey Complex Figure, and the
Block Design subtest taken from the WAIS-R. This factor is
therefore a mixture of general visuo-constructive/spatial
skills and non-verbal memory/new learning ability.
Factor 5: cognitive domain – "spatial working memory"
The highest loadings on this factor include key measures
taken from tests that comprise the CANTAB battery of
computerized tests (Spatial Span, Spatial Working Mem-
ory [both 'between errors' and 'strategy' scores] and The
Stockings of Cambridge minimum move solutions score).
Spatial Working Memory is the underlying cognitive skill
common to these tasks that could influence performance
on each. However, two of the 4 measures (i.e., Spatial
Working Memory 'strategy' score and Stockings of Cam-
bridge minimum move solutions), have also been con-
ceptualized as measures of 'executive' skill, and been
NISAT 'z' scores on the 'full' protocol Figure 1
NISAT 'z' scores on the 'full' protocol. NISAT 'z' scores on all 29 neuropsychological measures that comprise the 'full' 
protocol. Scores have a mean of 0 and a standard deviation of 1, and are standardized against a normal population. 1 = AMIPB 
Story immediate recall (IR); 2 = AMIPB Story delayed recall (DR); 3 = CVLT word list learning trials 1–5; 4 = CVLT list IR 5 = 
CVLT list DR; 6 = Paired associate Learning trials 7 = RMT 'words'; 8 = RMT 'faces'; 9 = Rey figure IR; 10 = Rey figure DR; 11 
= Rey figure copy; 12 = WAIS-R Block design; 13 = SDMT 'written'; 14 = SDMT 'oral'; 15 = CANTAB RVIP 'A' prime score; 16 
= SCOLP; 17 = Boston naming; 18 = NART IQ; [WAIS-R 19 = Similarities; 20 = Vocabulary; 21 = Digit Span; 22 = Arithmetic]; 
23 = Semantic fluency; 24 = Phonemic fluency; 25 = CANTAB IED adjusted errors score; 26 = CANTAB Spatial Working 
Memory (SWM) errors; 27 = CANTAB SWM strategy; 28 = CANTAB Spatial span; 29 = CANTAB Stockings Of Cambridge 
minimum move solutions.
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shown to be selectively sensitive to a variety of fronto-stri-
atal lesions [7,8].
Factor 6: cognitive domain – "executive skill"
Only one measure loads on this factor, the 'adjusted error'
score of the Intra-extra Dimensional Set-shifting task
taken from the CANTAB battery. This task is a decomposi-
tion of the Wisconsin Card Sorting Task, and the 'adjusted
error' score is a measure of the extent to which patients
encounter increasing difficulties as they proceed through
escalating task demands, delineated by the ability to make
intra-dimensional and then extra-dimensional set-shifts.
Difficulty negotiating the latter set-shift is conceptualized
as an impairment in one component of executive skills.
Raw scores from the 449 patients who completed the 21
'paper and pencil' measures in the 'core' protocol (exclud-
ing NART) were then entered into a PCA. This produced a
four-factor solution, which converged after 9 iterations.
The resulting pattern matrix (Table 1) shows the factor
loadings for each variable on these four factors after rota-
tion. The pattern of correlations indicated that these four
factors (verbal memory, general verbal skills, processing
speed and non-verbal skill/memory) mapped very closely
onto factors 1, 2, 3 and 4 from the six factor solution, with
more or less the same key tests loading > 0.4. These find-
ings suggested that four 'core' factors emerged consistently
despite the different sample sizes (i.e., 'core' protocol 449
compared to 'full' protocol 376), and the additional CAN-
TAB computerised test battery in the 'full' protocol. The
addition of the CANTAB tests in the 'full' battery rather
yielded two additional and distinct cognitive domains
(i.e., factors 5 and 6 on the six factor solution).
We identified those patients with individual factor scores
falling ≤ 5th percentile on each factor for the six (i.e., 'full'
protocol; n = 376) and four (i.e., 'core' protocol n = 449)
factor solutions (see Table 4). With respect to the first four
equivalent factors across each of the two solutions, Table
4 demonstrates there was a very high level of agreement
(i.e., > 97%) in identifying those individuals with scores
either above or below a 5th percentile cut-off. We also
compared agreement between the four and six factor solu-
tions on the same sample of 376 patients, and found that
this also yielded > 97% agreement in identifying those
individuals who fell above and below a 5th percentile cut-
off.
A sliding scale of CCRs
Table 5 presents a sliding scale of the percentage of
patients with 0–10 (or greater) cognitive deficits (defined
by a raw score falling ≤ 5th percentile relative to normative
data) on cognitive measures drawn from three samples.
Firstly, all 376 patients who completed the 'full' battery of
measures, secondly, all 449 patients who completed the
'core' battery of measures, and finally all 560 patients who
completed at least 10 measures. For each of these samples
percentage deficit rates with and without 'SAH-related'
missing data are included.
Table 5 illustrates that, with some consistency, including
SAH-related missing data as 'impairments' increases the
overall CCR progressively, moving up the scale toward
greater severity of impairment. Thus, the more measures a
patient is impaired on, the more likely they are to have
SAH-related missing data. In the 'full' sample of 376
patients there was a CCR of between 20.7% to 36.4%,
depending on whether the cut-off is drawn at 6 or more,
or 4 or more test impairments respectively. By adding
SAH-related missing data, these percentages increase up to
the range 29.6% to 43.6%. A similar distribution is appar-
ent when examining all 560 patients who completed at
least 10 test measures. Here the CCR without SAH-related
missing data is in the range 23.8% to 39.8% (for cut-offs
of 6–4 respectively) rising to the range 28.2% to 42.9%,
where missing data are included. Table 5 also illustrates
that significantly fewer patient impairments were identi-
fied within the 'core' sample, where fewer tests were
administered.
Table 6 presents the percentage of patients classified as
having no deficit, or mild, moderate or severe deficits. The
percentage of patients with 'no deficit' was very similar for
the sample of 376 patients with all measures available
from the 'full' protocol, and patients drawn from the
much larger sample of 560 patients who only completed
Table 4: Comparison of the 4 factor and 6 factor solutions. Comparison of which patients are a < 5th % percentile cut-off, on 
comparable factors for the 4 and 6 factor solutions. Values in the table are percentage of the sample for which both factors are 
available (i.e., n = 376). Numbers of patients are in brackets.
Factor
VM GVS PS NVS-M
Agree: above cut-off 93.6 (352) 92.6 (348) 93.4 (351) 94.9 (357)
Agree: below cut-off 4.5 (17) 5.1 (19) 4.0 (15) 3.5 (13)
Disagreement 1.9 (7) 2.4 (9) 2.6 (10) 1.6 (6)Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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at least 10 measures. Approximately a third of the sample
(between 31.8% to 33.8%) was essentially unimpaired
cognitively in these terms. The CCR for patients classified
with 'mild' and 'moderate' degrees of deficit was also very
similar between these two samples, falling in the range
28.4% to 29.8% for a 'mild' deficit, and 21.6% to 21.8%
for a 'moderate' deficit. These ranges applied within 1%
whether SAH-related missing data was included or not.
Table 6 therefore reinforces the observation that the
greater the number of deficits patients have, the greater
the additional 'deficit-loading' added by including SAH-
related missing data. It is also apparent from Table 5 and
6 that the completed 'core' battery of 'pencil and paper'
tests, though comprising a more substantial sample,
yielded a much smaller CCR.
A PCA-derived cognitive domain CCR
Test measures were grouped into cognitive 'domains'
based upon the factors that emerged from the PCA analy-
sis. For the purpose of illustration the percentage number
of patients from the full and core samples with 3 as well
as 2 deficits (i.e., on measures that load in each cognitive
domain) are presented in Tables 7 and 8. The percentage
CCR for each of the PCA-derived cognitive domains is pre-
sented for both the 'full' and the 'core' samples, both with
and without SAH-related missing data included.
The figures in brackets (Table 7 and 8) represent the per-
centage of deficits in the GVS and PS domains if verbal flu-
ency subtests are placed in the GVS rather than PS
domain. Under these circumstances there is a shift in the
distribution of deficits from the PS to the GVS domain,
illustrating that GVS deficits are clearly infrequent when
evaluated on the basis of WAIS-R verbal subtests alone.
However it was found that shifting verbal fluencies into
the criteria for evaluating GVS rather than the PS domain,
revised the overall CCR downward by only 1% (see Table
3).
The percentage CCR across the first four factor domains
drawn from both the 6 factor 'full' sample solution and
the 4 factor 'core' sample solution were very similar (i.e.,
most differences < 2%), except in the case of PS. Here
however, the higher number of deficits identified in the 6
Table 6: The percentage of patients with increasing levels of impairment. The percentage of N-ISAT patients classified with no deficit, 
and 'mild, 'moderate' and 'severe' levels of impairment. No deficit = ≤ 1 impaired score on measures, a mild deficit is 2 or 3 impaired 
scores, a moderate deficit is 4–6 impaired scores, and a severe deficit is > 7 impaired scores
FULL protocol sample CORE protocol sample Patients completing at least 10 measures
No missing data 
(n = 376)
Including missing 
data (n = 459)
No missing data 
(n = 449)
Including missing 
data (n = 509)
Not counting 
missing data 
(n = 560)
Counting missing 
data (n = 560)
No deficit 33.8 29.0 46.1 43.6 31.8 29.8
Mild deficit 29.8 27.4 27.9 25.7 28.4 27.3
Moderate deficit 21.8 19.4 15.8 16.9 21.6 20.2
Severe deficit 14.6 24.2 10.2 13.8 18.2 22.7
Table 5: The percentage of N-ISAT patients with cognitive deficits on an escalating number of 1–10 measures. Means are taken for the 
immediate and delayed recall of AMIPB, CVLT, Rey Figure, and for 2 subtests of SDMT. For the complete battery and "At least 10 
measures" group, 24 measures are therefore included. For the core test group 17 measures are included. All patients have passed 
screening assessment.
FULL protocol sample CORE protocol sample Patients completing at least 10 measures
No missing data 
(n = 376)
Including missing 
data (n = 459)
No missing data 
(n = 449)
Including missing 
data (n = 509)
Not counting missing 
data (n = 560)
Counting missing 
data (n = 560)
0 16.0 13.5 24.9 23.6 13.8 13.4
1+ 84.0 86.5 75.1 76.4 86.2 86.6
2+ 66.2 71.0 53.9 56.4 68.2 70.2
3+ 47.6 54.0 36.5 40.5 50.0 53.0
4+ 36.4 43.6 26.1 30.6 39.8 42.9
5+ 27.9 35.9 18.3 22.6 30.0 34.1
6+ 20.7 29.6 14.0 18.1 23.8 28.2
7+ 14.6 24.2 10.2 13.8 18.2 22.7
8+ 12.0 21.1 6.2 9.8 14.8 19.6
9+ 8.5 17.4 3.8 6.9 11.4 16.4
10+ 6.6 15.0 2.9 5.7 8.4 13.8Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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factor solution can be explained by the inclusion of
impaired scores from the RVIP in the PS domain (a meas-
ure that was not available to the core sample).
Tables 7 and 8 illustrate that in the N-ISAT sample deficits
in memory were clearly salient, together with non-verbal
skills/memory and executive skill. In contrast verbal sub-
tests from the WAIS-R were clearly insensitive to any cog-
nitive changes.
When the '4 factor domain' solution derived from the
'core' sample is applied to the 'full' sample of 376
patients, 84 individuals were identified as having a cogni-
tive complication, as compared to the 120 patients identi-
fied employing the 6 factor solution. This finding
suggested that 46% more patients were identified using
the more extensive and sophisticated 'full' protocol of
tests.
Summary CCR
Table 3 presents CCRs, as the percentage of patients with
deficits in 1, 2, or 3 PCA-derived cognitive domains (for
both 'full' and 'core' samples with and without SAH-
related missing data). Patients with deficits in two or more
domains would be broadly equivalent to deficits on 4 or
more tests, but would preferentially tend to exclude those
patients with more randomly distributed deficits across
tests, and place the emphasis rather upon those patients
with some internal consistency in the pattern of their def-
icits. Thus, whereas in the sliding scale analysis there were
36.4% – 43.6% of patients from the 'full' sample with 4 or
more deficits, the equivalent number of deficits grouped
together into their cognitive domains yields a CCR of
between 31.9% – 38.8%, (depending upon whether SAH-
related missing data is included).
In our view calculating a CCR from the 'full' sample (n =
376) on the basis of 2 or more impairments on tests that
load in 2 or more of 6 domains (see Table 3) represents a
Table 8: Percentage of patients impaired in each of 4 cognitive domains. Numbers are the percentage of the 'core' samples who had at 
least 2 or at least 3 impaired scores in each of the 4 domains. Numbers in brackets are for fluency in the GVS domain rather than PS 
domain. An impaired score or deficit is defined as one falling < 5%ile.
Cognitive domain
1 (VM) 2 (GVS) 3 (PS) 4 (NVS-M)
2+ measures
No missing data (n = 449) 32.3 6.9 (17.4) 17.4 (11.1) 28.7
Including missing data (n = 509) 34.8 9.4 (20.4) 23.4 (17.5) 29.3
3+ measures
No missing data (n = 449) 23.8 2.0 (6.2) 8.2 (2.4) 16.0
Including data missing (n = 509) 25.7 4.1 (8.6) 14.3 (9.2) 16.5
Table 7: Percentage of patients impaired in each of 6 cognitive domains. Numbers are the percentage of the 'full' samples who had (a) 
at least 2 and (b) at least 3 impaired scores in each of the 6 PCA-derived cognitive domains (n.b. domain 6 has 1 measure). Numbers in 
brackets are for where verbal fluency scores were placed in the in the GVS domain rather than PS domain. An impaired score is 
defined as < 5 percentile.
Cognitive domain
1 (VM) 2 (GVS) 3 (PS) 4 (NVS-M) 5 (SWM) 6 (ES)
2+ measures
No missing data (n = 376) 32.2 5.3 (16.5) 21.8 (14.9) 26.3 8.8 19.4
Including missing data (n = 459) 35.9 9.8 (21.4) 29.6 (23.7) 28.8 17.4 21.4
3+ measures
No missing data (n = 376) 23.9 1.3 (5.9) 11.4 (6.4) 14.1 2.4 19.4
Including missing data (n = 459) 27.0 4.6 (9.8) 20.3 (15.9) 16.3 10.5 21.4Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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reasonable algorithm for identifying patients with clini-
cally significant cognitive deficits, with an approximate
balance between the risk of type 1 and type 2 errors. This
method on a sub-sample of 376 patients yields a CCR of
31.9% without the inclusion of any missing data.
This CCR is however based on only 64% of those patients
potentially available for inclusion from N-ISAT. Table 9
presents the distribution of additional cases that can be
included in the CCR, if the criteria for their inclusion are
optimised, given the availability of measures, in the fol-
lowing way:
1. After the 'full' sample, the next most complete and con-
sistent body of test data, is provided by those additional
73 patients who completed the 'core' (but not the full)
protocol. By including these cases (now representing
together with the 'full' sample, 76% of potentially availa-
ble patients; i.e., 376 + 73 = 449), and identifying those
patients (n = 25) with 2 or more deficits in 2 or more of 4
cognitive domains, the overall complication rate rises to
32.3%.
2. Patients with a 'core' protocol but some missing data
(i.e., in the 'core' protocol) can then be included in the
CCR by re-coding their missing data as impairments; 32 of
these 60 patients had 2 or more deficits calculated in this
way, in 2 or more cognitive domains. The CCR then rises
to 34.8% based upon 509 cases (i.e., 376+73+60 = 509),
which represents 87% of potentially available patients.
3. By then examining an additional 51 patients who com-
pleted at least 10 test measures, a further 16 were identi-
fied who were impaired on 5 or more tests (without
consideration of their missing data). This yielded an over-
all CCR of 34.5% based upon 560 patients (i.e.,
376+73+60+51 = 560).
4. The next set of adjustments to the overall CCR can be
made by including those 7 patients who failed to com-
plete at least 10 test measures and 6 patients who failed
the pre-assessment screening battery of tests for reasons
related to the index SAH. These inclusions adjusted the
CCR to 36%.
5. As a correction for the risk of making a type 1 error in
these analyses (i.e., including patients in a CCR who's
scores on tests at < 5th percentile was attributable to pre-
morbid intellectual skills at < 5th percentile), we excluded
all those 16 patients with NART estimated pre-morbid IQs
of ≤ 75. This correction reduced the CCR marginally to
34.1%.
6. Finally, if all those 29 patients who failed to attend the
assessment for SAH-related reasons are included, the CCR
rises to 37.4% for the entire sample (see Table 9).
In order to illustrate the functional significance of a cogni-
tive 'complication' as detailed in Table 9, we compared
the ratings of all those patients so classified with those not
included in the CCR, on the UK version of the Sickness
Impact Profile [6], The Functional Limitations Profile
(FLP). Table 10 presents patients' and their carer/relatives'
ratings on the Total, Physical and Psychosocial dimen-
sions of the FLP. Across all FLP domains, patients with a
cognitive complication had significantly higher (i.e.,
worse) percentage disability ratings.
Discussion
As the UK based sub-study of the main ISAT trial, employ-
ing significantly different and potentially far more sensi-
tive measures, the priority analysis in N-ISAT was to
evaluate which of the two arms of the trial had preferen-
tial cognitive outcomes. This task was compromised by a
body of non-random missing data in N-ISAT. On the one
hand some patients did not present for assessment, while
on the other, some who attended failed to complete the
full test battery. A crucial aspect of these difficulties was
outside the control of the investigators, related to the way
in which clinical outcomes from the trial itself skewed the
Table 9: The N-ISAT summary CCR
Step Patient Samples No of patients in 
each CCR group
No of patients with 
deficits in each CCR 
group
CCR for each group of 
additional patients (%)
Cumulative total 
number of patients
Cumulative 
CCR (%)
1 Full protocol 376 120 31.9 376 31.9
2 Core protocol 73 25 34.2 449 32.3
3C o r e  +  m i s s i n g  d a t a 60 32 53.3 509 34.8
4 Completed at least 10 
measures*
51 16 31.4 560 34.5
5 Failed 10 measures 
screen
7 7 100 567 35.3
6 Failed initial screen 6 6 100 573 36.0
7 Remove those with IQ ≤ 
75
-16 -16 - 557 34.1
8 Those not seen for 
reason related to SAH
29 29 100 586 37.4Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
Page 13 of 15
(page number not for citation purposes)
availability of neuropsychological data. However, feeding
into this process was also the missing data that might be
attributed to the length of the test battery. If increased lev-
els of disability in one arm of the trial made it more likely
that patients in that arm would not complete all the tests
administered, clearly, it could be argued that a shorter test
protocol might have reduced the likelihood of this occur-
ring. In this sense, one of the unique strengths of N-ISAT
– the sophistication of the chosen neuropsychological
battery, was also a potential weakness.
The comprehensive nature of N-ISAT neuropsychological
test protocol may have increased the likelihood of missing
data, however we believe that by virtue of the controlled
methods that must be applied in their face-to-face acqui-
sition, all neuropsychological data, are routinely vulnera-
ble in this respect. Further, in NISAT fully 25% of patients
were 'lost to follow-up' in addition to the 34% who
attended but failed to complete the full protocol (includ-
ing from 1 to x missing data points); this suggests that the
problem of patients' failure to attend may be nearly as
salient as ensuring that the assessment is completed once
they do. In any event, the purpose of a test battery must be
carefully considered before implementation. For example,
a battery designed to simply identify patients with a rela-
tively severe level of overall (i.e., non-specific) cognitive
impairment could be much briefer than the more exten-
sive batteries that are necessary to pick up milder or more
subtle cognitive impairment, (or enable the fractionation
of brain-behaviour relationships). As mortality and mor-
bidity rates improve across interventional medicine, it is
likely that the distribution of less severe or more subtle
cognitive impairment may become increasingly impor-
tant in differentiating preferred outcomes [9]. Detecting
these more subtle deficits is likely to require more sophis-
ticated and possibly longer test batteries. Our analysis sug-
gested for example that within our sample of 376 patients
(with complete data sets), the 'full' N-ISAT test protocol
identified approximately 43% more patients as being sig-
nificantly impaired than the more limited 'core' protocol.
For the purpose of refining the representation of multiple
endpoints and accommodating the problems of non-ran-
dom missing data, we have described a systematic process
by which individual patients with more or less complete
neuropsychological profiles, might be classified as having
acquired a cognitive 'complication'. The CCR we have
derived should properly be viewed as an estimate as there
is no available or agreed external validation criterion
against which it can be referenced. Nevertheless the proc-
ess by which we have arrived at this estimate is in our view
relatively straightforward, as it is based upon well-estab-
lished analyses (i.e., PCA) and principles of clinical prac-
tice (the 5th percentile cut-off for 'impaired' z-scores). On
the basis of clinical experience and expertise we have also
introduced into this framework a number of adjustments
and corrections to refine the estimate. Where consensus is
less secure, we have relied upon transparency to accom-
modate a range of opinion. Thus for example we present
CCR estimates with and without SAH-related missing data
incorporated, and illustrate the consequences for cogni-
tive domains based upon different numbers of impaired
test scores, and a CCR based upon different numbers of
'impaired' cognitive domains. Tables 3, 6, 7 and 8 there-
fore might be seen as presenting a range of 'confidence
intervals' for a CCR, depending upon what assumptions
are made about the significance of different distributions
of impaired test scores.
In clinical practice, Neuropsychologists are required rou-
tinely, to make dichotomous judgements about whether
or not an individual is suffering from a functionally signif-
icant level of cognitive impairment. These judgements are
characteristically based upon both quantitative and qual-
itative information, and negotiated with the patient. Thus,
in addition to a profile of psychometric test scores, a
patient's clinical presentation, medical history, 1st or 3rd
party subjective reports of sequelae, the results from ques-
tionnaires or other clinical scales, might all be employed
to provide a context for interpretation. However in con-
trast the identification of individuals with a cognitive
'complication' (i.e., that are assumed to have a 'function-
ally significant' level of cognitive impairment) in a trial
Table 10: FLP ratings for patients with and without a cognitive complication. Self and carer/relative ratings on the FLP, for patients 
with and without a cognitive complication. The sample corresponds to row 7 of table 9 with patients with an IQ < 75 re-included (n = 
573)
FLP Measure Cognitive Deficit No Cognitive Deficit
Physical – self 11.29 4.63 *
Physical – carer 11.66 4.76*
Psychosocial – self 19.59 12.18*
Psychosocial – carer 17.56 10.95*
Total – self 15.24 8.16*
Total – carer 14.51 7.59*
* p < 0.001 (independent sample t-test, equal variances not assumed)Trials 2008, 9:13 http://www.trialsjournal.com/content/9/1/13
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the size of N-ISAT is, in the first instance, compelled to
proceed on the basis of profile of psychometric test scores
alone – a profile that is only one piece in the complex puz-
zle that is overall clinical outcome.
Though psychometric tests have the potential to be exqui-
sitely sensitive measures of outcome following brain dis-
ease or injury, the functional significance of cognitive
impairment may be more or less salient, depending upon
a number of other factors. These might include for exam-
ple, patients' subjective awareness of their impairment,
their pre-morbid work or social status, or the presence of
other neurological or psychological sequelae. It could be
argued that the information that is crucial from the point
of view of clinicians, trialists and most importantly the
patients themselves is whether the impairment is func-
tionally significant. In order to unravel and understand
the complex associations between the different perspec-
tives on 'outcome' from the neuropsychometric through
the subjective to the functional, criteria for classifications
of cognitive 'impairment' from a psychometric point of
view must first be determined. The validity (or functional
significance) of these classifications can then be tested
and explored with reference to other contemporaneous
measures of outcome. In N-ISAT, for example there are
interview, HQOL questionnaire and mRS outcome data
available for this purpose, though it is beyond the scope
of this paper to explore these relationships fully.
Conclusion
The evaluation of neuropsychological outcome in a large
multi-centre RCT involves a number of unique organiza-
tional and methodological challenges. The measures
employed may need sufficient range and sensitivity to
sample adequately deficits that could be associated with a
potentially heterogeneous distribution of brain lesions.
However, an assessment of this length and sophistication
yields potentially, a number of difficulties both in terms
of its acquisition and subsequent analysis, including
problems associated with having a large number of end-
points contaminated by missing data.
We have demonstrated in the N-ISAT data set that such
problems can be met by exploring transparently, ways in
which 29 neuropsychological outcomes can be classified
and summarised. Establishing individual clinical out-
comes comprising either the presence or absence of a 'cog-
nitive complication' required an algorithm based upon
the establishment of 2 'cut-offs'. Firstly a score below
which individuals' performance on each measure could
be said to be 'impaired', and secondly the number and/or
distribution of 'impaired' scores identified in this way,
required to classify and individual as having a clinically
significant cognitive 'complication'. Placing the first of
these cut-offs at the 5th percentile is in our view uncontro-
versial. However we would anticipate a greater range of
opinion regarding where the second cut-off should fall.
We have therefore presented a 'sliding scale' of cognitive
impairment. We further refined this analysis in 2 ways.
Firstly, by classifying patients according to the number of
acquired deficits, and secondly by taking into account the
distribution of deficits, in terms of a PCA-derived set of
cognitive domains (and the most representative measures
included therein). Throughout these analyses we have
presented the estimated CCRs, both with and without
consideration for missing data of potential clinical signif-
icance. Employing these methods we have estimated an
overall CCR in N-ISAT of 34.1% for all those 557 patients
who were seen face-to-face for assessment, and found that
this group of patients had significantly more disability on
a Health Related Quality of Life questionnaire, than
patients classified as having no functionally significant
cognitive deficits.
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